Gregory Smith Bentley serves as Executive at KV PHARMACEUTICAL CO /DE/, where they oversee executive responsibilities. Since joining the company, Gregory Smith Bentley has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 16, 2013 involved transacting 10 shares valued at $0.
Gregory Smith Bentley currently holds 7,500 shares of KV PHARMACEUTICAL CO /DE/ (KVA/KVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Smith Bentley has been a net neutral trader of KVA/KVB stock. They have purchased $0 and sold $0 worth of shares.
Gregory Smith Bentley's most recent insider trade was on Sep 16, 2013, when they sold 10 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 10, 2010 | KVA/KVB | $0 | Award | 7,500 | $N/A | Discretionary |